Doug Cole

Doug Cole

Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX),...
Alan Crane, MBA

Alan Crane, MBA

Alan Crane is a Partner and Entrepreneur at Polaris Partners focusing on building and investing in healthcare companies. He has served as founder and/or has played a significant role as chairman and CEO in building six Polaris companies including: Momenta...
Mahesh Karande

Mahesh Karande

Mahesh is the President and CEO of Omega Therapeutics (Nasdaq: OMGA), a clinical-stage biotechnology company pioneering a new field of epigenomic programming to use mRNA therapeutics as programmable epigenetic medicines. At Omega, he has led the translation of...
Ravi Mehrotra, PhD

Ravi Mehrotra, PhD

Ravi Mehrotra joined Flagship Pioneering in 2023. He works with  Flagship Growth companies to help maximize value creation opportunities for their bioplatforms. Prior to joining Flagship, Ravi spent 20+ years in biotechnology equity research and investment banking and...
Richard Moscicki, MD

Richard Moscicki, MD

Richard Moscicki has more than 25 years of leadership experience in translational medicine, clinical development, regulatory affairs and medical affairs in the pharmaceutical industry. Rich is currently the Executive Vice President for Science and Regulatory Advocacy...